Tight-binding inhibition by α-naphthoflavone of human cytochrome P450 1A2

被引:39
作者
Cho, US
Park, EY
Dong, MS
Park, BS
Kim, K
Kim, KH
机构
[1] Korea Univ, Grad Sch Biotechnol, Sungbuk Gu, Seoul 136701, South Korea
[2] Woosong Univ, Sch Food Sci & Biotechnol, Taejon 300718, South Korea
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS | 2003年 / 1648卷 / 1-2期
关键词
human cytochrome P450 1A2; alpha-naphthoflavone; tight-binding inhibition;
D O I
10.1016/S1570-9639(03)00148-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human cytochrome P450 (P450) enzymes exhibit remarkable diversity in their substrate specificities, participating in oxidation reactions of a wide range of xenobiotic drugs. Previously, we reported that alpha-naphthoflavone (ANF) is bound to the recombinant P450 1A2 tightly and stabilizes an overall enzyme conformation. The present study is designed to determine the type of P450 1A2 inhibition exerted by ANF, using two different substrates of P450 1A2, 7-ethoxycoumarin (EOC) and 7-ethoxyresorufin (EOR). ANF is generally known as a competitive inhibitor of the enzyme. However, in our tight-binding enzyme kinetics study, ANF acts as noncompetitive inhibitor in 7-ethoxycoumarin O-deethylation (ECOD) (K-i = 55.0 nM), but as competitive inhibitor in 7-ethoxyresorufin O-deethylation (EROD) (K-i = 1.4 nM). Based on homology modeling studies, ANIF is positioned to bind to a hydrophobic cavity next to the active site where it may cause a direct effect on substrate binding. It is agreed with the predicted binding site of ANIF in P450 3A4, in which ANIF is rather known as a stimulating modulator. Our results suggest that ANIF binds near the active site of P450 1A2 and exhibits differential inhibition mechanisms, possibly depending on the molecular structure of the substrate. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:195 / 202
页数:8
相关论文
共 36 条
[1]  
[Anonymous], PHYTOCHEMICAL DICT H
[2]   OXIDATION OF BENZO[A]PYRENE BY RECOMBINANT HUMAN CYTOCHROME-P450 ENZYMES [J].
BAUER, E ;
GUO, ZY ;
UENG, YF ;
BELL, LC ;
ZELDIN, D ;
GUENGERICH, FP .
CHEMICAL RESEARCH IN TOXICOLOGY, 1995, 8 (01) :136-142
[3]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[4]  
Butler AM, 1997, J PHARMACOL EXP THER, V280, P966
[5]   HUMAN CYTOCHROME P-450PA (P-450IA2), THE PHENACETIN O-DEETHYLASE, IS PRIMARILY RESPONSIBLE FOR THE HEPATIC 3-DEMETHYLATION OF CAFFEINE AND N-OXIDATION OF CARCINOGENIC ARYLAMINES - (AROMATIC-AMINES HETEROCYCLIC AMINES CARCINOGEN METABOLISM) [J].
BUTLER, MA ;
IWASAKI, M ;
GUENGERICH, FP ;
KADLUBAR, FF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (20) :7696-7700
[6]   Influence of ligand binding to human cytochrome P-450 1A2:: conformational activation and stabilization by α-naphthoflavone [J].
Cho, US ;
Ahn, HJ ;
Park, EY ;
Dong, MS ;
Kim, KH .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2001, 1546 (02) :412-421
[7]   GRAPHICAL DETERMINATION OF KM AND KI [J].
DIXON, M .
BIOCHEMICAL JOURNAL, 1972, 129 (01) :197-&
[8]  
Domanski TL, 2000, J PHARMACOL EXP THER, V293, P585
[9]  
Gryczynski Z, 1997, METHOD ENZYMOL, V278, P538
[10]  
Guengerich FP, 1995, CYTOCHROME P, P473